Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis

NCT05553236 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

2500

Enrollment

OTHER

Sponsor class

Conditions

Drug-resistant Tuberculosis
HIV Coinfection
Cost-Benefit Analysis

Interventions

DIAGNOSTIC_TEST: Targeted next-generation sequencing

Sponsor

University of California, San Francisco

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]